Skip to content
Synovo
Toggle menu
  • Home
  • Services
    • Summary Services
    • Disease Models
    • Chemistry Services
    • Histology
  • Innovation
  • TeamScience
  • Career
  • News
  • Contact

Category: Science

26. August 202229. August 2022Science

News from our Infection Department

Together with our colleagues from Amsterdam and Leiden, we have taken a closer look into the antiinfective and immunomodulating effects our in-house […]

20. July 202220. July 2022Science

Publication Highlight: Novel JAK3 Inhibitor

One of our premier internal research projects involves the development of novel, selective inhibitors of Janus kinase 3, a compound class of […]

19. July 202219. July 2022Science

Latest Publications

It has been a successful year so far for our scientists in the Synovo labs with a number of publications. We are […]

8. May 201810. September 2018Science

One step closer

After an intense ECCMID in Madrid, surrounded by the world top initiatives in the topic of infectious diseases, we are more and […]

1. February 201818. March 2018Grants, Science

Our anti-microbial program has been funded

We announce funding for our breakthrough anti-microbial research program by the Netherlands NACTAR program from the Netherlands organization for Scientific Research (NWO). […]

26. August 20178. January 2018Company life, Science

Study 1000!!

Thanks to those who believe in us and let us participate in the development of their products by providing pharmacology services. We […]

25. February 20158. January 2018Science

Synovo and ophthalmology

We expand business to ophthalmologyTübingen, Germany, February 2014. Synovo, a company focused on drug discovery and preclinical development, today announced the strategic […]

Synovo GmbH
Paul-Ehrlich-Str. 15
72070 Tübingen
Germany

Synovo GmbH
Paul-Ehrlich-Str. 15
D-72076, Tübingen
Germany

T +49 (0) 7071 964325
F +49 (0) 7071 964326
contact@synovo.com

NOVIRUSES2BRAIN

Legal Notice

Datenschutzerklärung
© 2023 Synovo. Proudly powered by Sydney